Newsroom

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today announced it will host a conference call and webcast to present data from the VRDN-008 phase 1 clinical trial in healthy volunteers and development plans for its neonatal Fc receptor (FcRn) portfolio on Monday, November 9, 2026, at 8:00 a.m. ET. Conference Call and...

NEW YORK--(BUSINESS WIRE)--Link Logistics (the “Company”), a leading operator of last-mile industrial real estate and warehouse properties, today announced it has invested more than $10 million through its employee-led Community Grants Program since launching the initiative in 2022. This milestone underscores the Company’s commitment to supporting local organizations and strengthening the communities where it operates. The Community Grants Program is powered by Link Logistics employees who subm...

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Presents 56-Week Phase 3 Data in Pediatric Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy for Camzyos......

BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a clinical-stage targeted oncology company focused on developing first-in-class and best-in-class cancer therapies, announced today that on November 2, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of non-statutory stock options to purchase an aggregate of 206,700 shares of common stock and 103,350 restricted stock units (“RSU...

AUSTIN, Texas--(BUSINESS WIRE)--Faeth Therapeutics (Nasdaq: FTH), a clinical- stage biotechnology company developing multi-node therapies for cancer patients, including its lead program PIKTOR, today announced that it will host a virtual event on Monday, November 9 at 8:00 AM ET to discuss topline results from its Phase 2 PIK-201 trial exploring PIKTOR in advanced endometrial cancer. To register, click here. The event will feature key opinion leader and PIK-201 principal investigator David Star...

COLLIERVILLE, Tenn.--(BUSINESS WIRE)--Mueller Industries, Inc. (NYSE: MLI) announced today that its Board of Directors has declared a regular quarterly cash dividend on its common stock of 17.5 cents per share. The dividend will be payable December 18, 2026 to shareholders of record on December 4, 2026. Mueller Industries, Inc. (NYSE: MLI) is an industrial corporation whose holdings manufacture vital goods for important markets such as air, water, oil and gas distribution; climate comfort; food...

BELLWOOD, Ill.--(BUSINESS WIRE)--G&H (Gooch & Housego), a leading provider of advanced photonics solutions, today announced its acquisition of IntraAction Corp., bringing together two established businesses with a long heritage in acousto-optic technology. “We are continuing to invest in acquisitions that accelerate G&H’s ability to bring enhanced value to our customers in strategic growth areas. The combined businesses will offer increased capacity, a broader portfolio and a strong...

LOS ANGELES--(BUSINESS WIRE)--CBRS Investors Have Opportunity to Join Cerebras Systems Inc. Fraud Investigation with the Schall, Brown & Schwartz LLP...

LOS ANGELES--(BUSINESS WIRE)--TENX Investors Have Opportunity to Lead Tenax Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law...

COSTA MESA, Calif.--(BUSINESS WIRE)--Experian a annoncé aujourd’hui avoir été nommée leader dans le rapport IDC MarketScape: Worldwide Decision Intelligence Platforms 2026 Vendor Assessment (Doc #US54118426, septembre 2026), qui évalue les fournisseurs aidant les organisations à concevoir, élaborer et orchestrer des processus décisionnels de plus en plus complexes. « À mesure que les organisations intègrent l’IA dans des décisions aux enjeux de plus en plus importants, la combinaison de données...